搜索
Pacira Biosciences Inc
PCRX添加自选
24.690USD
+0.210+0.86%
收盘 09-17 16:00（美东）
982.42M总市值
195.93市盈率 TTM
Pacira Biosciences Inc (PCRX) 营收表现
更新时间: 2026年6月30日业务
营业收入
占比
年报
年报
单季报
EXPAREL
ZILRETTA
iovera
Bupivacaine liposome injectable suspension
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
EXPAREL
575.13M(79.56%)
548.96M(78.74%)
538.12M(80.05%)
536.90M(80.84%)
506.51M(93.98%)
417.80M(97.93%)
ZILRETTA
116.63M(16.14%)
118.09M(16.94%)
111.10M(16.53%)
105.52M(15.89%)
12.68M(2.35%)
--(--)
iovera
24.18M(3.34%)
22.81M(3.27%)
19.68M(2.93%)
15.26M(2.30%)
16.16M(3.00%)
8.82M(2.07%)
Bupivacaine liposome injectable suspension
6.91M(0.96%)
7.32M(1.05%)
3.34M(0.50%)
6.48M(0.98%)
3.61M(0.67%)
--(--)